Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.15% Brimonidine Tartrate in Glaucoma and Ocular Hypertension
NCT02003534Phase 4Completed
- Sponsor
- Allergan
- Start
- Jul 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Jul 2010; status: completed.
02
Drugs
brimonidine
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT02003534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003534.